TARO PHN 100 TARO PHN 100 Pill: orange, capsule/oblong, 16mm
The pill with imprint TARO PHN 100 TARO PHN 100 (Orange, Capsule/Oblong, 16mm) has been identified as Phenytoin Sodium Extended 100 mg and is used for Epilepsy, Seizures, Neurosurgery, Status Epilepticus, and Seizure Prophylaxis During or Following Neurosurgery. It belongs to the drug class hydantoin anticonvulsants and is not a controlled substance.
Images for TARO PHN 100 TARO PHN 100




Phenytoin Sodium Extended
- Imprint
- TARO PHN 100 TARO PHN 100
- Strength
- 100 mg
- Color
- Orange
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Hydantoin anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Taro Pharmaceuticals U.S.A., Inc.
- Inactive Ingredients
-
sucrose,
lactose monohydrate,
magnesium stearate,
magnesium silicate,
benzyl alcohol,
butylparaben,
D&C Yellow No. 10,
edetate calcium disodium,
FD&C Red No. 3,
methylparaben,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
51672-4111 | Taro Pharmaceuticals USA, Inc. |
53002-1501 | Pharmedix (repackager) |
60429-0296 | Golden State Medical Supply (repackager) |
See also:
More about phenytoin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (117)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: hydantoin anticonvulsants
- Breastfeeding
Patient resources
Other brands
Dilantin, Phenytek, Phenytoin Sodium, Prompt
Professional resources
- Phenytoin, Phenytoin Sodium monograph
- Phenytoin Capsules (FDA)
- Phenytoin Chewable Tablets (FDA)
- Phenytoin Infatabs (FDA)
- Phenytoin Oral Suspension (FDA)
Other brands
Dilantin, Phenytoin Sodium, Phenytek
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.